CSIMarket


Protokinetix Incorporated  (PKTX)
Other Ticker:  
 

Protokinetix Incorporated

PKTX's Fundamental analysis








Protokinetix Incorporated's sales fell in III. Quarter 2023 from the same quarter a year ago.

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.74 %

Protokinetix Incorporated net loss deacreased by in III. Quarter 2023 year on year, Protokinetix Incorporated net loss increased by -78.28 % in III. Quarter 2023 year on year,

More on PKTX's Growth


Protokinetix Incorporated
reported net loss of -2 millions in the past twelve months.

Company
PE TTM   
Industry
333.47
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.5.


More on PKTX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $)

Protokinetix Incorporated
reported net loss of -2 millions in the past twelve months.

Company
PE TTM   
Industry
333.47
PE TTM    
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.5.